Related Experiment Videos

Defects in G1-S cell cycle control in head and neck cancer: a review

Rob J A M Michalides1, Michiel van de Brekel, Fons Balm

  • 1Division of Tumor Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. rmichal@nki.nl

Head & Neck
|July 12, 2002
PubMed

Insights

Cancer progresses through genetic changes affecting cell growth and spread. Dysregulation of cell cycle proteins like cyclins and cyclin-dependent kinases is key, especially in head and neck cancers, offering therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Tumorigenesis is a multistep process involving genetic alterations.
  • These alterations impact critical cellular functions like proliferation, apoptosis, and metastasis.
  • Genes controlling cell cycle and cell interactions are frequently affected.

Purpose of the Study:

  • To review genetic alterations in tumor progression.
  • To highlight the role of cell cycle regulators (cyclins, CDKs) in cancer.
  • To focus on genetic defaults in head and neck cancer.

Main Methods:

  • Review of fundamental cancer research over the past 30 years.
  • Analysis of genetic defects in tumor progression.
  • Emphasis on cell cycle control mechanisms.

Main Results:

  • Genetic defects drive tumor progression by affecting proliferation, cell death, and metastasis.
  • Cyclins and cyclin-dependent kinases are crucial regulators of the cell cycle (G1/S phase) and cell interactions.
  • Dysregulation of these proteins is linked to tumor progression and is observed across various cancer types.

Conclusions:

  • Genetic alterations are fundamental to tumor development and progression.
  • Cell cycle regulators like cyclins and CDKs are critical targets for cancer therapy.
  • Specific genetic defaults, particularly in cell cycle regulation, are prevalent in head and neck cancers.

Related Concept Videos